IRIS Accounts Production v25.2.0.378 03283816 Board of Directors 1.9.24 31.8.25 31.8.25 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh032838162024-08-31032838162025-08-31032838162024-09-012025-08-31032838162023-08-31032838162023-09-012024-08-31032838162024-08-3103283816ns15:EnglandWales2024-09-012025-08-3103283816ns14:PoundSterling2024-09-012025-08-3103283816ns10:Director12024-09-012025-08-3103283816ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3103283816ns10:SmallEntities2024-09-012025-08-3103283816ns10:AuditExempt-NoAccountantsReport2024-09-012025-08-3103283816ns10:SmallCompaniesRegimeForDirectorsReport2024-09-012025-08-3103283816ns10:SmallCompaniesRegimeForAccounts2024-09-012025-08-3103283816ns10:FullAccounts2024-09-012025-08-310328381612024-09-012025-08-3103283816ns10:OrdinaryShareClass12024-09-012025-08-3103283816ns10:Director32024-09-012025-08-3103283816ns10:Director42024-09-012025-08-3103283816ns10:Director22024-09-012025-08-3103283816ns10:CompanySecretary12024-09-012025-08-3103283816ns10:RegisteredOffice2024-09-012025-08-3103283816ns5:CurrentFinancialInstruments2025-08-3103283816ns5:CurrentFinancialInstruments2024-08-3103283816ns5:Non-currentFinancialInstruments2025-08-3103283816ns5:Non-currentFinancialInstruments2024-08-3103283816ns5:ShareCapital2025-08-3103283816ns5:ShareCapital2024-08-3103283816ns5:RetainedEarningsAccumulatedLosses2025-08-3103283816ns5:RetainedEarningsAccumulatedLosses2024-08-3103283816ns5:PlantMachinery2024-09-012025-08-3103283816ns5:FurnitureFittings2024-09-012025-08-3103283816ns5:ComputerEquipment2024-09-012025-08-3103283816ns5:NetGoodwill2024-08-3103283816ns5:NetGoodwill2025-08-3103283816ns5:NetGoodwill2024-08-3103283816ns5:PlantMachinery2024-08-3103283816ns5:FurnitureFittings2024-08-3103283816ns5:ComputerEquipment2024-08-3103283816ns5:PlantMachinery2025-08-3103283816ns5:FurnitureFittings2025-08-3103283816ns5:ComputerEquipment2025-08-3103283816ns5:PlantMachinery2024-08-3103283816ns5:FurnitureFittings2024-08-3103283816ns5:ComputerEquipment2024-08-3103283816ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-3103283816ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3103283816ns10:OrdinaryShareClass12025-08-31
REGISTERED NUMBER: 03283816 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2025

FOR

ARDEN MEDICAL LIMITED

ARDEN MEDICAL LIMITED (REGISTERED NUMBER: 03283816)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 August 2025




Page

Company information 1

Balance sheet 2

Notes to the financial statements 4


ARDEN MEDICAL LIMITED

COMPANY INFORMATION
for the Year Ended 31 August 2025







DIRECTORS: S Wade
D W Wade
B Wade
Mrs A Wade





SECRETARY: Mrs A Wade





REGISTERED OFFICE: Unit 2 Arden Road
Arden Forest Industrial Estate
Alcester
Warwickshire
B49 6HN





REGISTERED NUMBER: 03283816 (England and Wales)





ACCOUNTANTS: C J Petty Limited
Chartered Accountants
Chestnut House
High Offley Road
Woodseaves
Stafford
Staffordshire
ST20 0LG

ARDEN MEDICAL LIMITED (REGISTERED NUMBER: 03283816)

BALANCE SHEET
31 August 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 21,160 28,214
21,160 28,214

CURRENT ASSETS
Stocks 2,850 2,545
Debtors 6 217,853 283,503
220,703 286,048
CREDITORS
Amounts falling due within one year 7 155,949 192,567
NET CURRENT ASSETS 64,754 93,481
TOTAL ASSETS LESS CURRENT
LIABILITIES

85,914

121,695

CREDITORS
Amounts falling due after more than one
year

8

(1,286

)

(4,822

)

PROVISIONS FOR LIABILITIES (3,935 ) (5,888 )
NET ASSETS 80,693 110,985

CAPITAL AND RESERVES
Called up share capital 9 10,000 10,000
Retained earnings 70,693 100,985
SHAREHOLDERS' FUNDS 80,693 110,985

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ARDEN MEDICAL LIMITED (REGISTERED NUMBER: 03283816)

BALANCE SHEET - continued
31 August 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit & loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 October 2025 and were signed on its behalf by:





D W Wade - Director


ARDEN MEDICAL LIMITED (REGISTERED NUMBER: 03283816)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 August 2025

1. STATUTORY INFORMATION

Arden Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Office equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit & Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2024 - 28 ) .

ARDEN MEDICAL LIMITED (REGISTERED NUMBER: 03283816)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 August 2025

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2024
and 31 August 2025 14,333
AMORTISATION
At 1 September 2024
and 31 August 2025 14,333
NET BOOK VALUE
At 31 August 2025 -
At 31 August 2024 -

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Office
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 September 2024
and 31 August 2025 335,384 91,937 31,437 458,758
DEPRECIATION
At 1 September 2024 320,509 81,428 28,607 430,544
Charge for year 3,719 2,627 708 7,054
At 31 August 2025 324,228 84,055 29,315 437,598
NET BOOK VALUE
At 31 August 2025 11,156 7,882 2,122 21,160
At 31 August 2024 14,875 10,509 2,830 28,214

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 198,612 283,503
Other debtors 19,241 -
217,853 283,503

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 41,235 470
Hire purchase contracts 3,857 3,857
Trade creditors 23,990 29,425
Taxation and social security 82,598 128,174
Other creditors 4,269 30,641
155,949 192,567

ARDEN MEDICAL LIMITED (REGISTERED NUMBER: 03283816)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 August 2025

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Hire purchase contracts 1,286 4,822

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
10,000 Ordinary £1 10,000 10,000